A proposal of Masayuki Nakamori (CSO) adopted for AMED research project

A proposal by Masayuki Nakamori, Professor of the Department of Neurology at Yamaguchi University, who also serves as CSO of our company, regarding the research and development of a drug to treat Repeat Expansion Diseases has been selected for the Practical Research Project for Rare/Intractable Diseases FY2024 by the Japan Agency for Medical Research and Development (AMED).

We will utilize this project to accelerate research and development of therapeutic drugs.